Wnt5a与Wnt11作为SARS-CoV-2患者ARDS生物标志物
该研究探讨Wnt5a/Wnt11作为SARS-CoV-2感染患者急性呼吸窘迫综合征(ARDS)生物标志物的潜力。SARS-CoV-2感染导致COVID-19,可进展为肺炎、ARDS和脓毒症,临床亟需快速指示疾病严重程度的生物标志物。Wnt配体为分泌型糖蛋白,其下游信号在胚胎发育和组织稳态中起关键作用。
要点
- Wnt5a/Wnt11可作为SARS-CoV-2患者ARDS的潜在生物标志物。
- COVID-19可表现为肺炎、ARDS和脓毒症,需生物标志物快速评估严重程度。
- Wnt配体下游信号参与胚胎发育与组织稳态。
核心结论
- Wnt5a/Wnt11可作为SARS-CoV-2患者ARDS的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Wnt5a/Wnt11 can be used as potential ARDS biomarkers for SARS-CoV-2 patients https://bit.ly/3lxEGRA Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread globally, resulting in declaration of pandemic emergency [1]. COVID-19 patients suffer from various symptoms of infection, including pneumonia, acute respiratory distress syndrome (ARDS) and sepsis. Some known antiviral drugs, including remdesivir, have been proposed as effective agents for the treatment of SARS-CoV-2 infection [2, 3]. Along with the development of potential therapeutics, there is urgency to mitigate the transmission and economic crisis of SARS-CoV-2 via identification of biomarkers that can rapidly indicate the severity of the disease in infected patients. Wnt ligands are secreted glycoproteins and their downstream signalling plays a pivotal role in embryonic development and tissue homeostasis.
引用
- Choi EY, Park HH, Kim H, et al. Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients. Eur Respir J. 2020. PMID: 32859680. doi:10.1183/13993003.01531-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。